Growth Metrics

Biofrontera (BFRI) Income from Continuing Operations (2020 - 2025)

Historic Income from Continuing Operations for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to -$6.6 million.

  • Biofrontera's Income from Continuing Operations fell 1728.7% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year decrease of 3688.56%. This contributed to the annual value of -$17.8 million for FY2024, which is 1178.28% up from last year.
  • Per Biofrontera's latest filing, its Income from Continuing Operations stood at -$6.6 million for Q3 2025, which was down 1728.7% from -$5.3 million recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Income from Continuing Operations peaked at $5.6 million during Q1 2022, and registered a low of -$16.0 million during Q3 2021.
  • For the 5-year period, Biofrontera's Income from Continuing Operations averaged around -$4.9 million, with its median value being -$4.2 million (2025).
  • As far as peak fluctuations go, Biofrontera's Income from Continuing Operations skyrocketed by 25735.71% in 2022, and later crashed by 197159.53% in 2025.
  • Biofrontera's Income from Continuing Operations (Quarter) stood at -$14.5 million in 2021, then soared by 80.8% to -$2.8 million in 2022, then skyrocketed by 226.61% to $3.5 million in 2023, then plummeted by 139.59% to -$1.4 million in 2024, then plummeted by 376.29% to -$6.6 million in 2025.
  • Its Income from Continuing Operations was -$6.6 million in Q3 2025, compared to -$5.3 million in Q2 2025 and -$4.2 million in Q1 2025.